Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
06/16/2005 | US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic; |
06/16/2005 | US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
06/16/2005 | DE10351315A1 2-Phenyl-benzofuran-Derivate, Verfahren zur ihrer Herstellung und ihre Verwendung 2-phenyl-benzofuran derivatives, processes for their preparation and their use |
06/16/2005 | CA2546647A1 Antidiabetic compounds comprising benzofuran and benzothiophene derivatives |
06/15/2005 | EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
06/15/2005 | EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives |
06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
06/15/2005 | EP1539693A1 Cannabinoid receptor agonists |
06/15/2005 | EP1539692A1 Furanone derivatives and methods of making same |
06/15/2005 | EP1539685A1 Mcp-1 receptor antagonists and method of use thereof |
06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
06/15/2005 | EP1539673A1 PROCESS FOR THE PREPARATION OF i N /i -MONOSUBSTITUTED &bgr;-AMINO ALCOHOLS |
06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
06/15/2005 | EP1539151A1 Biaryl compounds having anti-infective activity |
06/15/2005 | EP1539147A1 Methods of treating microbial infections in humans and animals |
06/15/2005 | EP1539136A2 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
06/15/2005 | EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
06/15/2005 | CN1628111A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |
06/15/2005 | CN1628097A Astaxanthin esters |
06/15/2005 | CN1628096A Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid |
06/15/2005 | CN1628095A Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
06/15/2005 | CN1626501A Process for preparing optically active nitro compounds and cyano compounds |
06/15/2005 | CN1206226C Method for preparing effective anti-virus cyclopropane derivative and intermediate used thereof |
06/15/2005 | CN1206218C Aryl phenyl substituted cyclic ketoenols |
06/15/2005 | CN1206207C Preparation method of cyanophthaofluoroaniline |
06/14/2005 | US6906105 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer |
06/14/2005 | US6906092 Method of inhibiting matrix metalloproteinases |
06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
06/14/2005 | US6906072 Central nervous system disorders |
06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
06/14/2005 | US6905799 Nonaqueous electrolytic solution and secondary battery containing the same |
06/09/2005 | WO2005051955A1 Novel compound and medicinal composition |
06/09/2005 | WO2005051938A1 Vitamin d receptor modulators |
06/09/2005 | WO2005051937A2 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
06/09/2005 | WO2005051936A1 Phenyl-furan compounds as vitamin d receptor modulators |
06/09/2005 | WO2005051935A1 Method for preparing phenyl heterocycles as cyclooxygenase-2 inhibitor |
06/09/2005 | WO2005051901A1 Anti-cancer agents |
06/09/2005 | WO2005051895A1 Organic compounds |
06/09/2005 | WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
06/09/2005 | WO2005051889A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents |
06/09/2005 | WO2005051875A1 Homogeneous process for the hydrogenation of dicarboxylic acids and/or anhydrides thereof |
06/09/2005 | WO2005051373A1 Receptor function regulating agent |
06/09/2005 | WO2005039552A3 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
06/09/2005 | WO2004080410A3 Furanose-type bicyclic carbohydrates with biological activity |
06/09/2005 | WO2004026223A3 CONTINUOUS PROCESS FOR THE PRODUCTION OF OPTICALLY PURE (S)-β HYDROXY-Ϝ-BUTYROLACTONE |
06/09/2005 | US20050124817 Method for the preparation of citalopram |
06/09/2005 | US20050124808 Using nickel or palladium coupling catalyst containing phosphine or phosphite ligands |
06/09/2005 | US20050124721 Bulky monomers leading to resins exhibiting low polymerization shrinkage |
06/09/2005 | US20050124693 Biguanide derivative and therapeutic agent for diabetes containing the same |
06/09/2005 | US20050124692 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
06/09/2005 | US20050124676 EP4 receptor antagonists |
06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
06/09/2005 | US20050124658 Decahydronaphtho[2,3-c]furan derivatives |
06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
06/09/2005 | US20050124654 Compounds and methods of use |
06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
06/09/2005 | US20050124559 Antimicrobial agent |
06/09/2005 | US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
06/09/2005 | DE10351842A1 m-Diaminobenzole und deren Säureaddukte sowie deren Verwendung in Färbemitteln m-diaminobenzenes and their acid adducts, and their use in colorants |
06/09/2005 | CA2547430A1 Receptor function regulating agent |
06/09/2005 | CA2545823A1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
06/09/2005 | CA2544857A1 Vitamin d receptor modulators |
06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
06/08/2005 | EP1538138A1 Substituted benzanilide compound and pest control agent |
06/08/2005 | EP1537125A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms |
06/08/2005 | EP1537095A1 Process for preparing functionalized -butyrolactiones from mucohalic acid |
06/08/2005 | EP1537080A1 Substituted spirocyclic ketoenols |
06/08/2005 | EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |
06/08/2005 | EP1536681A2 High concentration topical insecticide |
06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
06/08/2005 | EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
06/08/2005 | EP1252133B1 Pharmaceutical compounds |
06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
06/08/2005 | CN1623993A Cantharides amine and demethyl cantharides amine derivative and application in medicine thereof |
06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
06/08/2005 | CN1205202C N-carbanilides used as pesticides |
06/08/2005 | CN1205199C Perfume parent |
06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
06/08/2005 | CN1205184C Beta-lactan |
06/08/2005 | CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
06/08/2005 | CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
06/08/2005 | CN1205162C High-yield method of maleic anhydride produced by n-butane |
06/07/2005 | US6903228 Reacting phthalane salt with cuprous cyanide in diglyme; for production of citalopram |
06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
06/07/2005 | US6903134 Formulation comprising benzofuranone derivatives for protection against oxidative stress |
06/07/2005 | US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
06/07/2005 | US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
06/07/2005 | US6903047 Surface treatment; grafting/calcination |